Agilysys Inc vs Novartis AG — how do they compare? Agilysys Inc trades at $106.06 (market cap $3.00B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 98.5× Agilysys Inc's market cap, and Novartis AG pays a 3.07% dividend while Agilysys Inc pays none. Which is the better fit depends on your goals.
| AGYS | NVS | |
|---|---|---|
Market Cap | $3.00B | $295.37B |
Sector | Technology | Health |
52-Week High | $141.12 | $168.62 |
52-Week Low | $62.19 | $119.31 |
Enterprise Value | $2.90B | $336.69B |
Dividend Yield | — | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
Agilysys provides enterprise software and SaaS solutions for the hospitality industry. Its products specialize in point-of-sale, property management, and inventory systems for hotels, resorts, and cruise lines.
Read more on AGYS →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →